new glp-1 drug Retatrutide for weight loss: Study shows 30% body weight loss New oral GLP-1 drug delivers

Symptoms like redness at the injection site, headaches, or slight dizziness typically fade within two weeks

Experimental Diabetes Research

Maria N N, Manuel M GdLH, Maria M

doi: 10.3389/fnagi.2025.1617106 Received 23 April 2025 Accepted 30 June 2025 Published 18 September 2025 Volume 17 - 2025 Edited by Francisco Navarrete, Miguel Hernndez University of Elche, Spain Reviewed by Robert Fekete, New York Medical College, United States Yutaka Oji, Juntendo University, Japan Updates Copyright 2025 Chaudhary, Chaudhary and Rawat

If cloudiness persists, let the vial rest at room temperature for 5 minutes and swirl again